VEGF vascularization pathway in human intervertebral disc does not change during the disc degeneration process

Area of Science:

• Biomedical research
• Molecular biology
• Spinal research

Background:

• Intervertebral disc degeneration is linked to nerve and blood vessel ingrowth, causing back pain.
• Vascular endothelial growth factors (VEGFs) and their receptor 1 (VEGFR1) play roles in blood vessel formation.
• VEGFR1 exists in membrane-bound and soluble forms, with potential roles in regulating vascularization.

Purpose of the Study:

• To investigate changes in membrane and soluble VEGFR1 expression during intervertebral disc degeneration.
• To determine if VEGFR1 expression levels correlate with different stages of disc degeneration.

Main Methods:

• Quantitative real-time PCR (qRT-PCR) and immunoblotting were used to assess VEGFR1 expression.
• Microarray meta-analysis was performed on human disc degeneration samples.
• Expression was compared between degenerated human discs and healthy bovine discs.

Main Results:

• Both membrane and soluble VEGFR1 forms, along with classic vascularization pathway components, are constitutively expressed across human disc degeneration stages.
• Contrary to the hypothesis, classic vascularization pathway expression remained stable.
• Genes in alternative vascularization signaling pathways showed increased expression in severely degenerated discs.

Conclusions:

• The expression of classic vascularization pathways is stable during disc degeneration.
• Soluble VEGFR1 may not inhibit disc degeneration.
• Alternative vascularization pathways are implicated in the pathological progression of severe disc degeneration.